Neurologic Disorder Treatment Drug and Forecast Market

List of Tables
Table 1. Neurologic Disorder Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Neurologic Disorder Treatment Drug Market Drivers in Global Market
Table 3. Neurologic Disorder Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Neurologic Disorder Treatment Drug in Global Market
Table 5. Top Neurologic Disorder Treatment Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neurologic Disorder Treatment Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neurologic Disorder Treatment Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neurologic Disorder Treatment Drug Product Type
Table 9. List of Global Tier 1 Neurologic Disorder Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neurologic Disorder Treatment Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neurologic Disorder Treatment Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Neurologic Disorder Treatment Drug Product Offerings
Table 32. AbbVie Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 33. Acadia Pharmaceuticals Corporate Summary
Table 34. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offerings
Table 35. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 36. Acorda Therapeutics Biotechnology Corporate Summary
Table 37. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offerings
Table 38. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporate Summary
Table 40. Bayer Neurologic Disorder Treatment Drug Product Offerings
Table 41. Bayer Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 42. Biogen Corporate Summary
Table 43. Biogen Neurologic Disorder Treatment Drug Product Offerings
Table 44. Biogen Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 45. CSK Corporate Summary
Table 46. CSK Neurologic Disorder Treatment Drug Product Offerings
Table 47. CSK Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 48. Eisai Corporate Summary
Table 49. Eisai Neurologic Disorder Treatment Drug Product Offerings
Table 50. Eisai Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 51. F. Hoffmann La Roche Corporate Summary
Table 52. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offerings
Table 53. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 54. H Lundbeck Corporate Summary
Table 55. H Lundbeck Neurologic Disorder Treatment Drug Product Offerings
Table 56. H Lundbeck Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 57. Johnson and Johnson Corporate Summary
Table 58. Johnson and Johnson Neurologic Disorder Treatment Drug Product Offerings
Table 59. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Neurologic Disorder Treatment Drug Product Offerings
Table 62. Merck Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 63. Novartis Corporate Summary
Table 64. Novartis Neurologic Disorder Treatment Drug Product Offerings
Table 65. Novartis Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 66. Otsuka Pharmaceutical Corporate Summary
Table 67. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offerings
Table 68. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 69. Pfizer Corporate Summary
Table 70. Pfizer Neurologic Disorder Treatment Drug Product Offerings
Table 71. Pfizer Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 72. Sanofi Corporate Summary
Table 73. Sanofi Neurologic Disorder Treatment Drug Product Offerings
Table 74. Sanofi Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 75. Takeda Pharmaceutical Corporate Summary
Table 76. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offerings
Table 77. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 78. Teva Pharmaceutical Industries Corporate Summary
Table 79. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offerings
Table 80. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 81. UCB Corporate Summary
Table 82. UCB Neurologic Disorder Treatment Drug Product Offerings
Table 83. UCB Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 84. USWM Corporate Summary
Table 85. USWM Neurologic Disorder Treatment Drug Product Offerings
Table 86. USWM Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Neurologic Disorder Treatment Drug Segment by Type in 2021
Figure 2. Neurologic Disorder Treatment Drug Segment by Application in 2021
Figure 3. Global Neurologic Disorder Treatment Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neurologic Disorder Treatment Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neurologic Disorder Treatment Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurologic Disorder Treatment Drug Revenue in 2021
Figure 8. By Type - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 12. US Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 16. Germany Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 24. China Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biogen Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CSK Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eisai Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. H Lundbeck Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novartis Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pfizer Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sanofi Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. UCB Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. USWM Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)